11455 El Camino Real Ste 250 San Diego, CA 92130 meipharma.com
Mei Pharma's annual revenues are $10-$50 million (see exact revenue data) and has 10-100 employees. It is classified as operating in the Scientific Research & Development Services industry.
Mei Pharma's Annual Report & Profile shows critical firmographic facts:
What is the company's size? (Annual sales and employees)
What industry is the company in?
Mei Pharma is a publicly traded company on NCM using the ticker symbol MEIP.
Detailed information on company financials and operating reports can be found here:
NCM: MEIP
Note: Mei Pharma's revenues are gauged from an analysis of company filings.
Investor Activity
Mei Pharma has actively raised capital from investors. These investors may include private investors, venture capital firms, or other investment vehicles.
Date
Investors
Percent Raised
Target Size
May 30, 2018
20
100%
$75 MM
Complete list of funding rounds and total amounts in the Company Report
Trademark Applications
Trademark applications show the products and services that Mei Pharma is developing and marketing.
Mei Pharma doesn't have any recent trademark applications, indicating Mei Pharma is focusing on
its existing business rather than expanding into new products and markets.
Trademarks may include brand names, product names, logos and slogans.
Trademark
Date
ZANOVERSE pharmaceutical products for the treatment of cancer and immune-related diseases and disorders; pharmaceuticals for use in the treatment of oncological disorders and diseases and immune-related diseases and disorders
01/25/2021
ZANPHOS pharmaceutical products for the treatment of cancer and immune-related diseases and disorders; pharmaceuticals for use in the treatment of oncological disorders and diseases and immune-related diseases and disorders
07/10/2020
MEI PHARMA Pharmaceuticals for use in the treatment of oncological disorders, neurological disorders, and immune-related disorders
03/21/2012
See all trademarks and details in the Full Report.
Recession Risk
Determine whether Mei Pharma grew or shrank during the last recession. This is useful in estimating the
financial strength and credit risk of the company.
Compare how recession-proof Mei Pharma is relative to the industry overall.
While a new recession may strike a particular industry, measuring the
industry and company's robustness during the last recession estimates its ability to weather future recessions.
A competitive analysis shows these companies are in the same general field as Mei Pharma, even though they may not compete head-to-head.
These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines.
The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies.
Competitive advantage comes from offering better pricing or superior products/service.
These companies are similar in business line and location to Mei Pharma.
While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.
Future Competition: Mei Pharma's Fastest Growing Competitors
These companies are in the same general field as Mei Pharma and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.